Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
About this trial
This is an interventional treatment trial for Colorectal Neoplasms focused on measuring Colorectal Cancer, Oxaliplatin, VEGF inhibitor, Vatalanib, PTK787, Colon Cancer, Colorectal Carcinoma, Rectal Cancer, Colorectal Tumor
Eligibility Criteria
Inclusion criteria Confirmed adenocarcinoma of the colon or rectum in patients with metastatic disease One prior chemotherapy regimen with irinotecan and 5FU Evidence of progressive disease within 6 months after last dose of irinotecan WHO Performance Status of 0, 1, or 2 Measurable tumors Adequate hematologic status, liver and kidney function Life expectancy greater than 12 weeks Written informed consent obtained Exclusion criteria History or presence of central nervous system disease Patients with a history of another primary cancer within 5 years Prior chemotherapy within 3 weeks before entry to study Major surgery within 4 weeks or minor surgery within 2 weeks before entry to study Investigational drugs within 4 weeks before entry to study Prior therapy with oxaliplatin Peripheral neuropathy with functional impairment Female patients who are pregnant or breast feeding Any severe or uncontrolled medical condition which could prevent participation in study Chronic kidney disease Acute or chronic liver disease Patients taking Coumadin
Sites / Locations
- Comprehensive Cancer Institute
- Alaska Oncology and Hematology
- Arizona Clinical Research Center
- Northeast Arkansas Clinic
- Arkansas Cancer Research Center
- Little Rock Hematology & Oncology
- Highlands Oncology Group
- Comprehensive Blood and Cancer Center
- Providence St. Joseph Medical Center
- Compassionate Cancer Care Medical Group, Inc.
- California Oncology of the Central Valley
- Virginia K. Crosson Cancer Center
- Glendale Adventist Medical Center
- Scripps Green Hospital
- Wilshire Oncology Medical Group
- Pacific Shores Medical Group
- USC Norris Cancer Center
- Synergy Hematology-Oncology Medical Associates
- Novartis Investigative Site
- UCLA School of Medicine
- Eddie Hong-Lung Hu, M.D.
- North Valley Hematology/Oncology Medical Group
- Medical Oncology Care Associates
- Ventura County Hematology-Oncology Specialists
- Sierra View District Hospital
- Cancer Care Associates Medical Group, Inc.
- Santa Clara Valley Medical Center
- Sansum Santa Barbara Foundation Medical Clinic
- Santa Barbara Hematology Oncology Medical Group, Inc.
- San Diego Cancer Center Medical Group
- Mile High Oncology
- Rocky Mountain Cancer Center
- Manchester Hematology/Oncology Assoc.
- Washington Oncology/Hematology Center
- The Center for Hematology and Oncology
- Florida Cancer Specialists
- Hematology Oncology Associates
- University of Miami School of Medicine
- Oncology/Hematology Group of South Florida
- Hematology Oncology Associates of Treasure Coast
- Florida Medical Clinic
- Atlanta Cancer Care
- Office of Research
- Coastal Hematology & Oncology
- Lewis Hall Singletary Oncology Center
- North Idaho Cancer Center
- University of Chicago medical Center, Hematology/Oncology
- Oncology Hematology Associates of Central Illinois, PC
- Northshore Cancer Research Association
- Midwest Cancer Research Group
- Fort Wayne Medical Oncology & Hematology, Inc.
- Munster Community Hospital
- Cotton O'Neil Oncology Clinic
- Vijay Raghaven, M.D.
- Owensboro Medical Health System
- Cabrini Center for Cancer Care
- LSU Medical Center
- Tulane University Health Sciences Center
- LSU Health Sciences Center
- Maine Center for Cancer Medicine & Blood Disorders
- St. Agnes Healthcare
- Franklin Square Hospital Center
- Kaiser Permanente
- Fallon Clinic at Worcester Medical Center
- University of Michigan
- Spectrum Health -- Cook Research Dept.
- Providence Cancer Center
- Oncology Care Associates, PLLC
- Minnesota CGOP
- Heartland Hematology
- Missouri Cancer Care, PC
- Saint Louis University
- Washington University School of Medicine
- Missouri Baptist Cancer Center
- Arch Medical Services Incorporated
- North Central Montana Professional Building
- Comprehensive Cancer Centers of Nevada
- Nevada Cancer Center
- NH Oncology-Hematology, PA
- Center for Cancer and Hematologic Disease
- St. Barnabas Cancer Center
- Hematology Oncology Associates of Northern New Jersey
- Cooper Cancer Center
- Hematology/Oncology Associates
- New Mexico Oncology/Hematology
- Roswell Park Cancer Institute
- Hematology/Oncology Associates of Central NY
- Queens Medical Associates, PC
- Charles R. Wood Cancer Center
- North Shore University Hospital
- St. Vincent's Catholic Medical Centers of New York
- Hematology-Oncology Associates of Rockland
- Pluta Cancer Center
- James P. Wilmot Cancer Center
- Lineberger Comprehensive Cancer Center
- Carolinas Hematology/Oncology Associates
- Nashat Gabrail, M.D.
- Case Western Reserve University
- The Cleveland Clinic Foundation
- Columbus CCOP
- The University of Oklahoma Health Sciences Center
- Oklahoma Oncology, Inc.
- Consultants in Medical Oncology & Hematology
- Hematology & Oncology Associates of NE PA
- Penn State Hershey Medical Center
- Monongahela Valley Hospital
- Thomas Jefferson University Hospital
- Allegheny General Hospital
- UPMC Cancer Pavillion
- Charleston Cancer Center
- South Carolina Oncology Associates
- WJB Dom VAMC
- Cancer Center of the Carolinas
- Spartanburg Regional Medical Center
- Erlanger Health System
- Clarksville Regional Hematology/Oncology
- The Jones Clinic
- Baptist Regional Cancer Center
- University of Tennessee Cancer Institute
- Sarah Cannon Cancer Center
- Meharry Medical College
- Vanderbilt-Ingram Cancer Center
- Vanderbilt University School of Medicine
- Harrington Cancer Center
- Center for Oncology Research & Treatment
- Clinical Hematology & Oncology
- Oncology Consultants
- H. Alejandro Preti, M.D., PA
- M.D. Anderson Cancer Center
- South Texas Oncology & Hematology
- Scott & White Hospital
- Northern Utah Cancer Associates
- Southwestern Vermont Health Care
- Virginia Oncology Associates
- Cancer Treatment Centers of America in Hampton Roads
- Western Washington Clinic
- Cascade Cancer Center
- Rainier Oncology
- Virginia Mason Medical Center
- Swedish Cancer Institute
- West Virginia University Health Sciences Center
- Waukesha Memorial Hospital
- Kettle Morain Oncology
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
1
2
Oxaliplatin/5-FU/LV and PTK787/ZK 222584
Oxaliplatin/5-FU/LV and placebo